CliffBio
small molecule

REPAGLINIDE AND METFORMIN HYDROCHLORIDE

METFORMIN HYDROCHLORIDE; REPAGLINIDE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameREPAGLINIDE AND METFORMIN HYDROCHLORIDE
Active ingredientMETFORMIN HYDROCHLORIDE; REPAGLINIDE
Strength500MG;2MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2015
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.